|
AUGUST 25, 2026 |
|
|
|
|
|
|
|
|
|
Key stat: 11% of US adults currently use a GLP-1 medication, up from just 3% two years earlier, according to a July report from Gallup. |
|
Beyond the chart: |
-
That growth is already rewiring household budgets. Households with a GLP-1 user have
cut grocery spending by 5.5% while raising apparel spending by 9.9% after six to eight months on the drug, according to PwC. |
| |
|
Use this chart: Drop this in your 2027 planning deck to argue GLP-1 users are a core audience, not a niche. Show it to category teams still treating these drugs as a health story. Use the three-year slope to justify a dedicated segment, then pair it with the spending shifts above to size the opportunity.
|
|
| | | |
|
|
|
|
|
Early-bird
pricing for EMARKETER’s The Future of Digital ends soon. Don’t miss your chance to join us at City Winery NYC for fresh data, analyst insights, and exclusive conversations with leaders from Gotham FC, LG Electronics, Colgate-Palmolive, JPMorgan Chase, Horizon Media, Ogilvy, Digitas North America, and more. Qualified brand marketers attend free, with discounted tickets for agencies. |
|
| | | |
|
Related EMARKETER reports:
|
| | | | |
EMARKETER has over 3,000 charts visualizing trends across digital advertising, ecommerce growth, Gen Z behavior, and more. See how clients use them to add credibility to strategy presentations, enhance pitch decks with market insights, and attract and engage prospects. |
Was this email forwarded to you? Sign up | | | | |
